Atypical Ocular Toxoplasmosis During Adalimumab Anti-Tumor Necrosis Factor Therapy for Rheumatoid Arthritis

J Clin Rheumatol. 2020 Dec;26(8):e279-e280. doi: 10.1097/RHU.0000000000001124.
No abstract available

MeSH terms

  • Adalimumab / adverse effects
  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / diagnosis
  • Arthritis, Rheumatoid* / drug therapy
  • Etanercept / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Toxoplasmosis, Ocular* / diagnosis
  • Toxoplasmosis, Ocular* / drug therapy
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Etanercept